Skip to main content

Canadian fertilizer maker Nutrien Ltd. on Monday cut its annual adjusted profit forecast as weaker-than-normal industrial demand held back prices for ammonia and urea ammonium nitrate.

The company cut the top end of its 2020 adjusted earnings per share forecast to $1.90 from $2.10 earlier, while retaining the lower end at $1.50.

Even as industrial utilization picked up in Asia, weak demand in Western Hemisphere hurt ammonia prices, Nutrien said.

The company said demand for urea was strong in India and expects Chinese urea exports to pick up pace in the second half, though they are lower year-on-year.

Revenue of $8.18 billion for the second quarter missed analysts’ estimate of $8.35 billion, according to Refinitiv IBES.

Potash sales volumes in North America rose from an increase in U.S. planted acreage and more normal weather this spring, but prices still suffered as the benchmark was dragged by weak demand abroad.

Net potash sales outside of North America declined about 40 per cent because of lower Chinese import demand and some short-term cautious spot purchasing in certain international markets, the company said.

The Saskatoon, Saskatchewan-based company’s net income fell to $765 million, or $1.34 per share, in the three months ended June 30, from $858-million, or $1.47 per share, a year earlier.

On an adjusted basis, it earned $1.45 per share, beating expectations of $1.33, helped by lower costs.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Report an editorial error

Report a technical issue

Tickers mentioned in this story

Study and track financial data on any traded entity: click to open the full quote page. Data updated as of 14/11/24 4:00pm EST.

SymbolName% changeLast
NTR-T
Nutrien Ltd
-0.55%65.2
NTR-N
Nutrien Ltd
-0.94%46.37

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe